100
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Long-Term Outcomes of Macular Hole Repair with Triamcinolone Acetonide Visualization

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1607-1619 | Published online: 16 Apr 2021

References

  • Spiteri Cornish K, Lois N, Scott NW, et al. Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole. Ophthalmology. 2014;121(3):649–655. doi:10.1016/j.ophtha.2013.10.020
  • Wang XW, Long Y, Gu YS, Guo DY. Outcomes of 4 surgical adjuvants used for internal limiting membrane peeling in macular hole surgery: a systematic review and network meta-analysis. Int J Ophthalmol. 2020;13(3):481–487. doi:10.18240/ijo.2020.03.17
  • Stanescu-Segall D, Jackson TL. Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety. Eye (Lond). 2009;23(3):504–518. doi:10.1038/eye.2008.249
  • Wu Y, Zhu W, Xu D, et al. Indocyanine green-assisted internal limiting membrane peeling in macular hole surgery: a meta-analysis. PLoS One. 2012;7(11):e48405. doi:10.1371/journal.pone.0048405
  • Kodjikian L, Richter T, Halberstadt M, et al. Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium. Graefes Arch Clin Exp Ophthalmol. 2005;243(9):917–925. doi:10.1007/s00417-004-1121-6
  • Gass CA, Haritoglou C, Schaumberger M, Kampik A. Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol. 2003;241(9):716–720. doi:10.1007/s00417-003-0710-0
  • Enaida H, Hisatomi T, Hata Y, et al. Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina. 2006;26(6):631–636. doi:10.1097/01.iae.0000236469.71443.aa
  • Jindal A, Pathengay A, Mithal K, Chhablani J, Pappuru RR, Flynn HW. Macular toxicity following brilliant blue G-assisted macular hole surgery - a report of three cases. Nepal J Ophthalmol. 2014;6(11):98–101. doi:10.3126/nepjoph.v6i1.10779
  • Sakamoto T, Miyazaki M, Hisatomi T, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol. 2002;240(6):423–429. doi:10.1007/s00417-002-0454-2
  • Thorne JE, Sugar EA, Holbrook JT, et al. Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. Ophthalmology. 2019;126(2):283–295. doi:10.1016/j.ophtha.2018.08.021
  • Macky TA, Helmy D, El Shazly N. Retinal toxicity of triamcinolone’s vehicle (benzyl alcohol): an electrophysiologic and electron microscopic study. Graefes Arch Clin Exp Ophthalmol. 2007;245(6):817–824. doi:10.1007/s00417-006-0459-3
  • Hahn P. ASRS 2020 Preferences and Trends Membership Survey. Chicago, IL: American Society of Retina Specialists; 2020.
  • Almeida FPP, De Lucca AC, Scott IU, Jorge R, Messias A. Accidental subretinal brilliant blue G migration during internal limiting membrane peeling surgery. JAMA Ophthalmol. 2015;133(1):85–88. doi:10.1001/jamaophthalmol.2014.3869
  • Venkatesh R, Aseem A, Jain K, Yadav NK. Combined brilliant blue G and xenon light induced outer retinal layer damage following macular hole surgery. Indian J Ophthalmol. 2020;68(1):247–249. doi:10.4103/ijo.IJO_1386_19
  • Gass JD. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol. 1995;119(6):752–759. doi:10.1016/s0002-9394(14)72781-3
  • Duker JS, Kaiser PK, Binder S, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120(12):2611–2619. doi:10.1016/j.ophtha.2013.07.042
  • Kumar A, Chawla R, Kumawat D, Pillay G. Insight into high myopia and the macula. Indian J Ophthalmol. 2017;65(2):85–91. doi:10.4103/ijo.IJO_863_16
  • Faghihi H, Hajizadeh F, Riazi-Esfahani M. Optical coherence tomographic findings in highly myopic eyes. J Ophthalmic Vis Res. 2010;5(2):110–121.
  • Kumar A, Gogia V, Shah VM, Nag TC. Comparative evaluation of anatomical and functional outcomes using brilliant blue G versus triamcinolone assisted ILM peeling in macular hole surgery in Indian population. Graefes Arch Clin Exp Ophthalmol. 2011;249(7):987–995. doi:10.1007/s00417-010-1609-1
  • Elhusseiny AM, Schwartz SG, Flynn HW Jr, Smiddy WE. Long-term outcomes after macular hole surgery. Ophthalmol Retina. 2020;4(4):369–376. doi:10.1016/j.oret.2019.09.015
  • Kampougeris G, Cheema R, McPherson R, Gorman C. Safety of Triamcinolone acetonide (TA)-assisted pars plana vitrectomy in macular hole surgery. Eye (Lond). 2007;21(5):591–594. doi:10.1038/sj.eye.6702265
  • Azuma K, Noda Y, Hirasawa K, Ueta T. Brilliant blue G-assisted internal limiting membrane peeling for macular hole: a systematic review of literature and meta-analysis. Retina. 2016;36(5):851–858. doi:10.1097/iae.0000000000000968
  • Mochizuki N, Yamamoto T, Enaida H, Ishibashi T, Yamashita H. Long-term outcomes of 3 surgical adjuvants used for internal limiting membrane peeling in idiopathic macular hole surgery. Jpn J Ophthalmol. 2014;58(6):455–461. doi:10.1007/s10384-014-0345-1
  • Nomoto H, Shiraga F, Yamaji H, et al. Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results. Retina. 2008;28(3):427–432. doi:10.1097/IAE.0b013e31815ec2f1
  • Williamson TH, Lee E. Idiopathic macular hole: analysis of visual outcomes and the use of indocyanine green or brilliant blue for internal limiting membrane peel. Graefes Arch Clin Exp Ophthalmol. 2014;252(3):395–400. doi:10.1007/s00417-013-2477-2
  • Ip MS, Baker BJ, Duker JS, et al. Anatomical outcomes of surgery for idiopathic macular hole as determined by optical coherence tomography. Arch Ophthalmol. 2002;120(1):29–35. doi:10.1001/archopht.120.1.29
  • Kang HK, Chang AA, Beaumont PE. The macular hole: report of an Australian surgical series and meta-analysis of the literature. Clin Exp Ophthalmol. 2000;28(4):298–308. doi:10.1046/j.1442-9071.2000.00329.x
  • Jaycock PD, Bunce C, Xing W, et al. Outcomes of macular hole surgery: implications for surgical management and clinical governance. Eye (Lond). 2005;19(8):879–884. doi:10.1038/sj.eye.6701679
  • Kumar A, Prakash G, Singh RP. Indocyanine green enhanced maculorhexis in macular hole surgery. Indian J Ophthalmol. 2002;50(2):123–126.
  • Patel SC, Loo RH, Thompson JT, Sjaarda RN. Macular hole surgery in high myopia. Ophthalmology. 2001;108(2):377–380. doi:10.1016/S0161-6420(00)00532-7
  • Yu Y, Liang X, Wang Z, et al. Internal limiting membrane peeling and air tamponade for stage III and stage IV idiopathic macular hole. Retina. 2020;40(1):66–74. doi:10.1097/iae.0000000000002340
  • Chen G, Tzekov R, Jiang F, Mao S, Tong Y, Li W. Inverted ILM flap technique versus conventional ILM peeling for idiopathic large macular holes: a meta-analysis of randomized controlled trials. PLoS One. 2020;15(7):e0236431. doi:10.1371/journal.pone.0236431
  • Caporossi T, Pacini B, De Angelis L, Rizzo S. Amniotic membrane plug to promote chronicpost-traumatic macular hole closure. Ophthalmic Surg Lasers Imaging Retina. 2019;51(1):50–52. doi:10.3928/23258160-20191211-07
  • Bhatnagar P, Kaiser PK, Smith SD, Meisler DM, Lewis H, Sears JE. Reopening of previously closed macular holes after cataract extraction. Am J Ophthalmol. 2007;144(2):252–259. doi:10.1016/j.ajo.2007.04.041
  • Paques M, Massin P, Blain P, Duquesnoy AS, Gaudric A. Long-term incidence of reopening of macular holes. Ophthalmology. 2000;107(4):760–5; discussion 766. doi:10.1016/s0161-6420(99)00182-7
  • Abbey AM, Van Laere L, Shah AR, Hassan TS. Recurrent macular holes in the era of small-gauge vitrectomy: a review of incidence, risk factors, and outcomes. Retina. 2017;37(5):921–924. doi:10.1097/iae.0000000000001252
  • Wu -T-T, Kung Y-H. Comparison of anatomical and visual outcomes of macular hole surgery in patients with high myopia vs. non-high myopia: a case-control study using optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250(3):327–331. doi:10.1007/s00417-011-1821-7
  • Qu J, Zhao M, Jiang Y, Li X. Vitrectomy outcomes in eyes with high myopic macular hole without retinal detachment. Retina. 2012;32(2):275–280. doi:10.1097/IAE.0b013e31821a8901
  • Ikuno Y, Sayanagi K, Soga K, Oshima Y, Ohji M, Tano Y. Foveal anatomical status and surgical results in vitrectomy for myopic foveoschisis. Jpn J Ophthalmol. 2008;52(4):269–276. doi:10.1007/s10384-008-0544-8
  • Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Nawrocki J. Inverted internal limiting membrane flap technique for surgical repair of myopic macular holes. Retina. 2014;34(4):664–669. doi:10.1097/iae.0000000000000042
  • Cacciamani A, Lazzeri S, Rossi T, et al. Adjustable macular buckling for full-thickness macular hole with Foveoschisis in highly myopic eyes: long-term anatomical and functional results. Retina. 2016;36(4):709–716. doi:10.1097/iae.0000000000000802
  • Tewari A, Almony A, Shah GK. Macular hole closure with triamcinolone-assisted internal limiting membrane peeling. Retina. 2008;28(9):1276–1279. doi:10.1097/IAE.0b013e31817d8be1
  • Leonard RE, Smiddy WE, Flynn HW, Feuer W. Long-term visual outcomes in patients with successful macular hole surgery. Ophthalmology. 1997;104(10):1648–1652. doi:10.1016/S0161-6420(97)30071-2
  • Li SS, You R, Li M, et al. Internal limiting membrane peeling with different dyes in the surgery of idiopathic macular hole: a systematic review of literature and network meta-analysis. Int J Ophthalmol. 2019;12(12):1917–1928. doi:10.18240/ijo.2019.12.15
  • Rishi P, Rishi E, Kothari A. Retinal pigment epithelial changes after trypan blue-assisted internal limiting membrane peeling for idiopathic macular hole. Oman J Ophthalmol. 2011;4(1):37–38. doi:10.4103/0974-620x.77663
  • Jain S, Kishore K, Sharma YR. Progressive atrophy of retinal pigment epithelium after trypan-blue-assisted ILM peeling for macular hole surgery. Indian J Ophthalmol. 2013;61(5):235–237. doi:10.4103/0301-4738.111180
  • Balaiya S, Brar VS, Murthy RK, Chalam KV. Comparative in vitro safety analysis of dyes for chromovitrectomy: indocyanine green, brilliant blue green, bromophenol blue, and infracyanine green. Retina. 2011;31(6):1128–1136. doi:10.1097/IAE.0b013e3181fe543a
  • Mikosz CA, Smith RM, Kim M, et al. Fungal endophthalmitis associated with compounded products. Emerg Infect Dis. 2014;20(2):248–256. doi:10.3201/eid2002.131257
  • Scupola A, Mastrocola A, Sasso P, et al. Assessment of retinal function before and after idiopathic macular hole surgery. Am J Ophthalmol. 2013;156(1):132–139.e1. doi:10.1016/j.ajo.2013.02.007
  • Payne JF, Bergstrom C, Yan J, Aaberg TM Sr, Srivastava SK. Residual triamcinolone acetonide sequestered in the fovea after macular hole repair. Retina. 2011;31(1):148–153. doi:10.1097/IAE.0b013e3181ea48a1
  • Kontos A, Tee J, Stuart A, Shalchi Z, Williamson TH. Duration of intraocular gases following vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol. 2017;255(2):231–236. doi:10.1007/s00417-016-3438-3
  • Hecht I, Mimouni M, Blumenthal EZ, Barak Y. Sulfur Hexafluoride (SF(6)) versus Perfluoropropane (C(3)F(8)) in the intraoperative management of macular holes: a systematic review and meta-analysis. J Ophthalmol. 2019;2019:1820850. doi:10.1155/2019/1820850
  • Zarranz-Ventura J, Sallam A, Keane P, Sim D, Kirkpatrick N, Johnston R. Macular hole surgery: does C3F8 provide better anatomical and functional outcomes than SF6 and C2F6? Invest Ophthalmol Vis Sci. 2013;54(15):5777.
  • Guerrero-Naranjo JL, Cortés-Luna C, Morales-Cantón V, et al. Cirugía de agujero macular sin posición ≪boca abajo≫ postoperatoria. Estudio piloto. [Macular hole surgery without postoperatory ≪face≫ down positioning. Pilot study]. Arch Soc Esp Oftalmol. 2006;81(6):321–326. doi:10.4321/s0365-66912006000600005
  • Solebo AL, Lange CA, Bunce C, Bainbridge JW. Face-down positioning or posturing after macular hole surgery. Cochrane Database Syst Rev. 2011;12:Cd008228. doi:10.1002/14651858.CD008228.pub2
  • Sakamoto T, Enaida H, Kubota T, et al. Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy. Am J Ophthalmol. 2004;138(1):137–138. doi:10.1016/j.ajo.2004.02.072
  • Asahi MG, Wallsh JO, Gallemore RP. Outcomes of epiretinal membrane removal utilizing triamcinolone acetonide visualization and internal limiting membrane forceps. Clin Ophthalmol. 2020;14:3913–3921. doi:10.2147/opth.s279611
  • Chen CJ. Glaucoma after macular hole surgery. Ophthalmology. 1998;105(1):94–9;discussion 99–100. doi:10.1016/s0161-6420(98)91470-1
  • Hakimbashi M, Rezaei K. Rate of elevated intraocular pressure post primary vitrectomy surgery. Invest Ophthalmol Vis Sci. 2013;54(15):5802.
  • Fang Y, Long Q, Wang X, Jiang R, Sun X. Intraocular pressure 1 year after vitrectomy in eyes without a history of glaucoma or ocular hypertension. Clin Ophthalmol. 2017;11:2091–2097. doi:10.2147/OPTH.S144985
  • Briand S, Chalifoux E, Tourville E, et al. Prospective randomized trial: outcomes of SF6 versus C3F8 in macular hole surgery. Can J Ophthalmol. 2015;50(2):95–100. doi:10.1016/j.jcjo.2014.12.006
  • Chen PP, Thompson JT. Risk factors for elevated intraocular pressure after the use of intraocular gases in vitreoretinal surgery. Ophthalmic Surg Lasers. 1997;28(1):37–42.
  • Mittra RA, Pollack JS, Dev S, et al. The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation after pars plana vitrectomy with long-acting gas tamponade. Ophthalmology. 2000;107(3):588–592. doi:10.1016/s0161-6420(99)00083-4
  • Huang YH, Tsai DC, Wang LC, Chen SJ. Comparison between cryopreserved and dehydrated human amniotic membrane graft in treating challenging cases with macular hole and macular hole retinal detachment. J Ophthalmol. 2020;2020:9157518. doi:10.1155/2020/9157518